We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Manual on Complex APIs Including Drug-Device Combinations
FDA Issues Manual on Complex APIs Including Drug-Device Combinations
The FDA’s Center for Drug Evaluation and Research (CDER) has released a Manual of Policies and Procedures (MAPP) document that explains how the agency will classify complex new drug products and drug-device combination products assigned to CDER.